PEGylated human catalase elicits potent therapeutic effects on H1N1 influenza-induced pneumonia in mice

Applied Microbiology and Biotechnology

Volumn 97, Issue 23, 2013, Pages 10025-10033

  Shi, Xunlong ^a   Shi, Zhihui ^a   Huang, Hai ^a   Zhu, Hongguang ^a   Zhu, Haiyan ^a   Ju, Dianwen ^a   Zhou, Pei ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Catalase; Influenza; Oxidative stress; PEGylation; Pneumonia

Indexed keywords

CATALASE; INFLUENZA; PEGYLATION; PNEUMONIA; POLYETHYLENE GLYCOL MONOMETHYL ETHER; REACTIVE OXYGEN SPECIES; THERAPEUTIC EFFECTS; THERAPEUTIC EFFICACY;

BIOLOGICAL ORGANS; OXIDATIVE STRESS; VIRUSES;

MAMMALS;

MACROGOL DERIVATIVE; PEGYLATED RECOMBINANT HUMAN CATALASE; REACTIVE OXYGEN METABOLITE; RECOMBINANT ENZYME; UNCLASSIFIED DRUG;

DISEASE CONTROL; DRUG; ENZYME ACTIVITY; INFECTIOUS DISEASE; PNEUMONIA; RODENT; SURVIVORSHIP; VIRUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG HALF LIFE; DRUG PURIFICATION; DRUG SYNTHESIS; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; LUNG INJURY; MOUSE; NONHUMAN; PNEUMONIA; RAT; SURVIVAL; THERAPY EFFECT; VIRUS LOAD; VIRUS REPLICATION;

INFLUENZAVIRUS A; MUS; TETRA;

ANIMALS; CATALASE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MICE; MICE, INBRED ICR; PNEUMONIA; POLYETHYLENE GLYCOLS; REACTIVE OXYGEN SPECIES;

EID: 84888205464     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-013-4775-3     Document Type: Article

References (32)

1. Baysal SH, Uslan AH (2001) Encapsulation of catalase and PEG-catalase in erythrocyte. ArtCells Blood Subs & Immob Biotech 29:359-366
2. Brian JD (2009) Catalase and glutathione peroxidase mimics. Biochem Pharmacol 77:285-296
3. Brown-Borg HM, Rakoczy SG (2000) Catalase expression in delayed and premature aging mouse models. Exp Gerontol 35:199-212
4. Case AJ, McGill JL, Tygrett LT, Shirasawa T, Spitz DR, Waldschmidt TJ, Legge KL, Domann FE (2011) Elevated mitochondrial superoxide disrupts normal T cell development, impairing adaptive immune responses to an influenza challenge. Free Radic Biol Med 50:448-458
5. Cerutti PA (1991) Oxidant stress and carcinogenesis. Eur J Clin Invest 21:1-5
6. Deng W, Baki L, Yin J, Zhou H, Baumgarten CM (2010) HIV protease inhibitors elicit volume-sensitive Cl - current in cardiac myocytes via mitochondrial ROS. J Mol Cell Cardiol 49:746-752
7. Derek G (2009) The 2009 H1N1 influenza outbreak in its historical context. J Clin Virol 45:174-178
8. Gangehei L, Ali M, Zhang W, Chen Z, Wakame K, Haidari M (2010) Oligonol a low molecular weight polyphenol of lychee fruit extract inhibits proliferation of influenza virus by blocking reactive oxygen species-dependent ERK phosphorylation. Phytomedicine 17:1047-1056
9. Guy J, Qi X, Hauswirth WW (1998) Adeno-associated viral-mediated catalase expression suppresses optic neuritis in experimental allergic encephalomyelitis. Proc Natl Acad Sci 95:13847-13852
10. Halliwell B, Gutteridge JM (1990) Role of free radicals and catalytic metal ions in human diseases: an overview. Methods Enzymol 168:1-85
11. Hanawa T, Asayama S, Watanabe T, Owada S, Kawakami H (2009) Protective effects of the complex between manganese porphyrins and catalase-poly (ethylene glycol) conjugates against hepatic ischemia/reperfusion injury in vivo. J Control Release 135:60-64
12. Hyoudou K, Nishikawa M, Umeyama Y, Kobayashi Y, Yamashita F, Hashida M (2004) Inhibition of metastatic tumor growth in mouse lung by repeated administration of polyethylene glycol-conjugated catalase: quantitative analysis with firefly luciferase-expressing melanoma cells. Clin Cancer Res 10:7685-7691
13. Hurt AC, Barr IG, Hartel G, Hampson AW (2004) Susceptibility of human influenza viruses from Australasia and Southeast Asia to the neuraminidase inhibitors zanamivir and oseltamivir. Antivir Res 62:37-45
14. Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van Loo G, Ermolaeva M, Veldhuizen R, Leung YH, Wang H, Liu H, Sun Y, Pasparakis M, Kopf M, Mech C, Bavari S, Peiris JS, Slutsky AS, Akira S, Hultqvist M, Holmdahl R, Nicholls J, Jiang C, Binder CJ, Penninger JM (2008) Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133:235-249
15. Kudchodkar BJ, Pierce A, Dory L (2007) Chronic hyperbaric oxygen treatment elicits an antioxidant response and attenuates atherosclerosis in apoE knockout mice. Atherosclerosis 193:28-35
16. Lv ZM, Sang LY, Li ZM, Min H (2009) Catalase and superoxide dismutase activities in a Stenotrophomonas maltophilia WZ2 resistant to herbicide pollution. Ecotoxicol Environ Saf 72:136-143
17. Michelle DT, Emma RJ, Andrew GB, Patrick CR (2011) Glycosylation of the hemagglutinin modulates the sensitivity of H3N2 influenza viruses to innate proteins in airway secretions and virulence in mice. Virology 413:84-92
18. Nakamura H, Tamura S, Watanabe Z, Iwasaki T, Yodoi J (2002) Enhanced resistance of thioredoxin-transgenic mice against influenza virus-induced pneumonia. Immunol Lett 82:165-170
19. Nishikawa M, Hashida M, Takakura Y (2009) Catalase delivery for inhibiting ROS-mediated tissue injury and tumor metastasis. Adv Drug Deliver Rev 61:319-326
20. Ogbeyalu EO, George EJ, Zhao YF, Zhou LC, Yang H, Guo ZM (2009) Overexpression of catalase delays G0/G1- to S phase transition during cell cycle progression in mouse aortic endothelial cells. Free Radic Biol Med 46:1658-1667
21. Rosenblum MD, Olasz E, Woodliff JE, Johnson BD, Konkol MC, Gerber KA, Orentas RJ, Sandford G, Truitt RL (2004) CD200 is a novel p53-target gene involved in apoptosis-associated immune tolerance. Blood 103:2691-2698
22. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H (2008) Epidemiology and etiology of childhood pneumonia. Bull World Health Organ 86:408-416
23. Ruuskanen O, Lahti E, Jennings LC, Murdoch DR (2011) Viral pneumonia. Lancet 9773:1264-1275
24. Shi XL, Feng MQ, Shi J, Shi ZH, Zhong J, Zhou P (2007) High-level expression and purification of recombinant human catalase in Pichia pastoris. Protein Expres Purif 54:24-29
25. Shi XL, Shi ZH, Huang H, Zhu HG, Zhou P, Ju DW (2010) Therapeutic effect of recombinant human catalase on H1N1 influenza-induced pneumonia in mice. Inflammation 33:166-172
26. Simonian NA, Coyle JT (1996) Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 36:83-106
27. Snelgrove RJ, Edwards L, Rae AJ, Hussell T (2006) An absence of reactive oxygen species improves the resolution of lung influenza infection. Eur J Immunol 36:1364-1373
28. Yabe Y, Nishikawa M, Tamada A, Takakura Y, Hashida M (1999) Targeted delivery and improved therapeutic potential of catalase by chemical modification: combination with superoxide dismutase derivatives. J Pharmacol Exp Ther 289:1176-1184
29. 2+ influx. Free Radic Biol Med 42:1949-1959
30. Yu G, Hong DK, Dionis KY, Rae J, Heyworth PG, Curnutte JT, Lewis DB (2008) Focus on FOCIS: the continuing diagnostic challenge of autosomal recessive chronic granulomatous disease. Clin Immunol 128:117-126
31. Wang JX, Zhou JY, Yang QW, Chen Y, Li X, Piao YA, Li HY (2008) An improved embryonated chicken egg model for the evaluation of antiviral drugs against influenza A virus. J Virol Methods 153:218-222
32. Wong SSY, Yuen KY (2008) Antiviral therapy for respiratory tract infections. Respirologv 13:950-971